Published: Jun, 2016
The global acute ischemic stroke diagnosis and treatment market is expected to reach US$1.869 bn before the end of 2020. It is progressing at a CAGR of 6.3% within a forecast period from 2014 to 2020. The market was valued at US$1.225 bn in 2013, according to the findings of a research report released by Transparency Market Research.The leading market intelligence provider has recently published a new report pertaining to the pharmaceutical sector, titled “Acute Ischemic Stroke Diagnosis and Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.” The market analysts have added a wide array of research points backed by expert opinions.
Browse the full Acute Ischemic Stroke Diagnosis and Treatment Market (By Diagnostics Type - CT, MRI, Ultrasound, Cerebral Angiography, Nuclear Imaging and Others; By Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at https://www.transparencymarketresearch.com/acute-ischemic-stroke-treatment.html
Acute ischemic strokes imply the loss of brain function created by the lack of blood supply to the brain. The most common cause of acute ischemic strokes is the formation of atherosclerosis plaques that narrow or block blood vessels. Another major cause is the formation of blood clots in the arteries to the brain.
According to the report, the primary factor responsible for the current growth rate of the global acute ischemic stroke diagnosis and treatment market is the increasing prevalence of the disease. This market’s growth rate is further supported by the developments that modern medicine and medical devices are allowing in it. Due to the incorporation of these developments, the success rate of surgeries is improving the world over, causing a higher growth rate to show over the given forecast period.
The report’s users can gain deep insights into the acute ischemic stroke diagnosis and treatment market based on its segmented analysis, through the categories of surgery type and diagnostic type. According to surgery type, this market is segmented into endovascular mechanical thrombectomy, angioplasty, and carotid endarterectomy.
Based on surgery type, this market was dominated by carotid endaterectomy in 2013, owing to easier availability, shorter length of treatment time, and a greater success rate. This segment could, however, experience a fall in market shares due to the presence of major side effects.
Based on diagnostic type, this market is segmented into nuclear imaging, cerebral angioplasty, ultrasound, magnetic resonance imaging, computed tomography, and others. Although CT has dominated the global acute ischemic stroke diagnosis and treatment market so far, it is expected to be steadily replaced by the MRI method, owing to higher efficiency and lower costs.
The report also provides a detailed geographical review of the acute ischemic stroke diagnosis and treatment market by segmenting it into the major zones of North America, Asia Pacific, Europe, and the Rest of the World.
Owing to a high patient pool and the presence of highly advanced technologies, this market was dominated by North America in 2013. The second-largest region in the acute ischemic stroke diagnosis and treatment market is Europe, owing to the rapidly increasing geriatric population across this region.
Meanwhile, Asia Pacific is showing the fastest growth rate among all major regions. This is attributed to the surging healthcare industry, the growing population density, and the rising rates of awareness and healthcare expenditures.
The key players in the global acute ischemic stroke diagnosis and treatment market are Hitachi, Ltd., GE Healthcare, Johnson & Johnson, Stryker Corporation, Penumbra, Inc., Philips Healthcare, Siemens Healthcare, Abbott Laboratories, and Covidien plc.
Key Segments of the Global Acute Ischemic Stroke Diagnosis and Treatment Market
- Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type
- Computed Tomography
- Magnetic Resonance Imaging
- Cerebral Angiography
- Nuclear Imaging
- Acute Ischemic Stroke Diagnosis and Treatment Market, by Surgery Type
- Carotid Endarterectomy
- Endovascular Mechanical Thrombectomy
- Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
- North America
- Rest of the World
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453